Acura Pharmaceuticals Common Stock Net 2010-2021 | ACUR

Acura Pharmaceuticals common stock net from 2010 to 2021. Common stock net can be defined as the value of common equity ownership.
Acura Pharmaceuticals Annual Common Stock Net
(Millions of US $)
2021 $1
2020 $0
2019 $0
2018 $0
2017 $0
2016 $0
2015 $0
2014 $0
2013 $0
2012 $0
2011 $0
2010 $0
2009 $0
Acura Pharmaceuticals Quarterly Common Stock Net
(Millions of US $)
2021-12-31 $1
2021-09-30 $1
2021-06-30 $1
2021-03-31 $0
2020-12-31 $0
2020-09-30 $0
2020-06-30 $0
2020-03-31 $0
2019-12-31 $0
2019-09-30 $0
2019-06-30 $0
2019-03-31 $0
2018-12-31 $0
2018-09-30 $0
2018-06-30 $0
2018-03-31 $0
2017-12-31 $0
2017-09-30 $0
2017-06-30 $0
2017-03-31 $0
2016-12-31 $0
2016-09-30 $0
2016-06-30 $0
2016-03-31 $0
2015-12-31 $0
2015-09-30 $0
2015-06-30 $0
2015-03-31 $0
2014-12-31 $0
2014-09-30 $0
2014-06-30 $0
2014-03-31 $0
2013-12-31 $0
2013-09-30 $0
2013-06-30 $0
2013-03-31 $0
2012-12-31 $0
2012-09-30 $0
2012-06-30 $0
2012-03-31 $0
2011-12-31 $0
2011-09-30 $0
2011-06-30 $0
2011-03-31 $0
2010-12-31 $0
2010-09-30 $0
2010-06-30 $0
2010-03-31 $0
2009-12-31 $0
2009-09-30 $0
2009-06-30 $0
2009-03-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.000B $0.000B
Halsey Drug Company, Inc. is engaged in the manufacture, sale and distribution of generic drugs. A generic drug is the chemical and therapeutic equivalent of a brand-name drug for which patent protection has expired. The company sells its generic drug products under its Halsey label and under private-label arrangements with drugstore chains and drug wholesalers.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $18.420B 6.58
Dr Reddy's Laboratories (RDY) India $12.089B 21.94
BridgeBio Pharma (BBIO) United States $8.831B 0.00
Bausch Health Cos (BHC) Canada $2.335B 1.68
Supernus Pharmaceuticals (SUPN) United States $1.811B 14.70
Amphastar Pharmaceuticals (AMPH) United States $0.972B 6.53
Taysha Gene Therapies (TSHA) United States $0.552B 0.00
Personalis (PSNL) United States $0.547B 0.00
Assembly Biosciences (ASMB) United States $0.143B 0.00
Sol-Gel Technologies (SLGL) Israel $0.023B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00
Teligent (TLGT) United States $0.000B 0.00